| Period Ending: |
LTM
(Last Twelve Months) |
2025 12-31 |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2026-03-09 | 2026-03-09 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | 2,747 | 2,747 | 1,676 | 1,450 | 772.1 | 84.88 | 15.44 |
| Cost of Revenue | 2,534 | 2,585 | 1,281 | 1,024 | 522.3 | 110.8 | 22.54 |
| Gross Profit | 212.6 | 161.5 | 395.5 | 426.7 | 249.7 | -25.91 | -7.1 |
| Operating Expenses | 307.6 | 252.6 | 228.3 | 157.2 | 287.9 | 60.18 | 23.79 |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative | 226.8 | 252.6 | 154.6 | 136.7 | 161.1 | 44.82 | 14.32 |
| Other Operating Expenses | 80.83 | 0 | 73.71 | 20.49 | 126.7 | 15.36 | 9.47 |
| Operating Income | -95.05 | -91.14 | 167.2 | 269.5 | -38.12 | -86.1 | -30.89 |
| Net Non-Operating Interest | 30.34 | 0 | 32.81 | 27.35 | 5.96 | -4.77 | -3.36 |
| Interest Income | 31.37 | 0 | 34.71 | 29.26 | 8.64 | 0 | 0 |
| Interest Expense | 1.03 | 0 | 1.91 | 1.91 | 2.68 | 4.77 | 3.36 |
| Equity & Other Income/(Expense) | -38.18 | -11.75 | 21.61 | 22.07 | -726.4 | -413 | 17.05 |
| Income Before Tax | -102.9 | -102.9 | 221.6 | 318.9 | -758.5 | -503.9 | -17.2 |
| Income Tax Expense | -33.38 | -33.38 | 64.58 | 47.4 | 3.26 | 4.85 | 0.115 |
| Income Attributable to Non-Controlling Interest | -0.01 | -0.01 | 1.32 | 3.99 | 7.08 | -0.507 | -21.1 |
| Net Income | -69.51 | -69.51 | 155.7 | 267.6 | -768.8 | -508.2 | 3.79 |
| Depreciation and Amortization | 76.63 | 76.63 | 50.85 | 34.89 | 13.28 | 3.94 | 4.5 |
| EBITDA | -18.42 | -14.52 | 218 | 304.4 | -24.84 | -82.15 | -26.39 |
| Earnings Per Share (EPS) | -1.89 | -0.29 | 2.86 | 5.66 | -16.48 | -11.47 | 0.086 |
| Diluted Earnings Per Share | -2.15 | -0.29 | 2.13 | 3.96 | -16.48 | -11.46 | 0.086 |
| Weighted Average Shares Outstanding | 242.3 | 242.3 | 54.41 | 47.27 | 46.66 | 44.3 | 44.3 |
| Diluted Weighted Average Shares Outstanding | 242.3 | 242.3 | 73.04 | 67.55 | 46.66 | 44.35 | 44.35 |
